NFE2L2 and cancer: In aggregate, these findings, in conjunction with the ability of CaMKK2 to regulate the NRF2 signaling and in turn ferroptosis in cancer cells (52), pinpoint Nrf2 as a potential relevant downstream target of CaMKK2 in MDSC.